BioNTech SE (BNTX) Net Income towards Common Stockholders (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Net Income towards Common Stockholders data on file, last reported at -$174.4 million in Q4 2025.

• For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 147.59% year-over-year to -$174.4 million; the trailing twelve-month figure through Dec 2025 stood at -$1.1 billion (down 41.52% YoY), and the FY2025 full-year result was -$1.1 billion, down 47.92% from the prior year.
• Net Income towards Common Stockholders slipped to -$174.4 million in Q4 2025, from $91.3 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $7.2 billion in Q3 2021 to a low of -$865.6 million in Q2 2024.
• A 5-year average of $1.7 billion and a median of $343.3 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders soared 1512953662792.27% in 2021 and tumbled 147.59% in 2025, its largest moves.
• Tracing BNTX's Net Income towards Common Stockholders over 5 years: stood at $3622.0 in 2021, then surged by 114544050.96% to $4.1 billion in 2022, then plunged by 77.48% to $934.5 million in 2023, then sank by 60.79% to $366.4 million in 2024, then plunged by 147.59% to -$174.4 million in 2025.
• Business Quant data shows BNTX's Net Income towards Common Stockholders at -$174.4 million in Q4 2025, $91.3 million in Q3 2025, and -$474.1 million in Q2 2025.